The four times per day administration of 0.5 % INDOM eye drops in eyes affected with uveitic ME from different etiologies , compared with placebo , is associated with a significant reduction in ME at the 6-month follow-up visit , as measured by spectral-domain optical coherence tomography ( SD-OCT ) .